Study: FDG-PET/CT can be used in staging Hodgkin's disease

12/16/2008 | (free registration)

U.K. researchers found that FDG-PET/CT exhibited high sensitivity and specificity in detecting focal bony disease in people with Hodgkin's disease. The findings indicate that FDG-PET/CT should be used in the initial staging of the disease and that bone marrow trephine biopsy should be used "far more judiciously," the scientists said.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC